Symposium explores AI's boundless promise—and potential dangers
Leading artificial intelligence experts grapple with complexities, opportunities that AI and data science bring to higher education
Source: jhu.edu
📰 Systems Biology Program News
Systems Biology Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Systems Biology Program. Real-time updates on events, politics, business and more.
Expansion of cell-to-cell communication drive
New research combined sophisticated genetically engineered mouse models and advanced computational methods to map the earliest cell states leading to pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer.
Comunidad Autonoma De Cataluna Baden Wüberg Vilniaus Apskritis Thomas Walle Cassandra Burdziak Doron Haviv
Source: eurekalert.org
AACR announces Fellows of the AACR Academy Cl
The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the AACR Academy.
United States City Of United Kingdom Virginia Commonwealth University New South Wales University Of California San Diego
Source: eurekalert.org
Study: Growth in corn crops fuels carbon dioxide level spike
Researchers discovered that growth in agricultural production is responsible for increase in C02 levels.
National Science Foundation Boston University Macrosystems Biology Program Northern Hemisphere National Science Systems Biology Program
Source: natureworldreport.com
2022-23 Takeda Fellows: Leveraging AI to positively impact human health
The 2022-23 MIT-Takeda Fellows are working on electronic health record systems, robot control, pandemic preparedness, traumatic brain injuries, and more.
Source: mit.edu
New atlas of small cell lung cancer reveals rare population of stem-like cells with metastatic properties
Imagine you're about to go on a cross-country trip, stopping at spots along the way to admire local attractions.
Source: news-medical.net
IDEAYA Reports Darovasertib (IDE196) Monotherapy Overall Survival Data and Observes Early Partial Responses in Binimetinib Combination in Metastatic Uveal Melanoma
IDEAYA Reports Darovasertib (IDE196) Monotherapy Overall Survival Data and Observes Early Partial Responses in Binimetinib Combination in Metastatic Uveal Melanoma - Darovasertib monotherapy results in 57% 1-year Overall Survival (OS) Rate in predominantly 2L / 3L and heavily pre-treated (out to 7L / 8L) MUM patients, where historical 1-year OS Rate has been reported at 37% - Darovasertib monotherapy median Overall Survival in MUM is 13.2 months, where historical median OS has been reported at ...
United States Meredith Mckean Richard Carvajal Sarah Cannon Research Institute At Tennessee Oncology Melanoma Service Irving Medical Center
Source: prnewswire.com